Breast Tissue Marker Systems

Aug 21, 2003
Breast Tissue Marker Systems
VENDOR PRODUCT NAME &
DEVICE CATEGORY 		SPECIFICATIONS
InRad
Kentwood, MI 		UltraClip 2 -- accessory
  • 3-mm titanium tissue marker for breast biopsy follow-up.
  • Visible with mammography and ultrasound.
    		•
    Ethicon Endo-Surgery
    Cincinnati, OH     		MicroMark II -- accessory
  • Tissue marker for postoperative breast biopsy monitoring.
  • Undetectable to patient, allows physician to keep track of an abnormality in future mammograms.
    • Artemis Medical
    Hayward, CA     		Mammomark --accessory
  • Collagen-based self-expanding breast biopsy marker with titanium clip.
  • After placement, hydrates, conforms to size and shape of biopsy cavity, can be visualized mammographically and on ultrasound.
  • Resorbs within weeks, leaving clip for long-term follow-up.
    		•
    SenoRx
    Aliso Viejo, CA     		Gel Mark -- accessory
  • Gelatin-based biopsy site marker visualized using ultrasound, mammography, and digital mammography.
  • Compatible with Mammotome and MIBB.
  • Disposable device releases gelatin pellets that hydrate and swell within the biopsy cavity, resorbing within a few weeks.
    		•
    Latest in Womens Imaging
    Breast Dbt 400
    Batch reading of DBT exams leads to reader performance boost
    November 12, 2024
    Images depict a 43-year-old woman with a malignant nonmass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic nonmass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected nonmass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
    Ultrasound nonmass breast lesion features may signal malignancy
    November 5, 2024
    Chat Gpt 400
    ChatGPT demonstrates mixed results in assigning BI-RADS categories
    November 1, 2024
    Ultrasound Breast 400
    ABUS screening improves breast cancer screening in low-resource areas
    October 29, 2024
    Related Stories
    Cc99 Ff Dot
    Breast
    Effective breast CAD still harbors a few workflow caveats
    2003 04 25 14 48 38 706
    Breast
    Breast cancer in younger women calls for flexibility in imaging
    2003 04 10 15 09 19 706
    Breast
    Contrast-enhanced 3-D US boosts mammography results
    2003 01 13 15 29 39 706
    Breast
    Start-up firm Photonify sees promise in optical imaging
    More in Womens Imaging
    Batch reading of DBT exams leads to reader performance boost
    By Amerigo Allegretto
    Batch reading of digital breast tomosynthesis (DBT) exams can improve the reading performance of radiologists.
    November 12, 2024
    Breast Dbt 400
    Ultrasound nonmass breast lesion features may signal malignancy
    By Amerigo Allegretto
    Some nonmass breast lesion characteristics on ultrasound exams can be considered suspicious for malignancy at screening ultrasound.
    November 5, 2024
    Images depict a 43-year-old woman with a malignant nonmass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic nonmass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected nonmass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
    ChatGPT demonstrates mixed results in assigning BI-RADS categories
    By Amerigo Allegretto
    ChatGPT achieves modest accuracy when assigning BI-RADS scores for mammograms and breast ultrasound exams.
    November 1, 2024
    Chat Gpt 400
    ABUS screening improves breast cancer screening in low-resource areas
    By Amerigo Allegretto
    Automated breast ultrasound (ABUS) with remote reading may improve access to breast cancer screening and early detection in low-resource settings.
    October 29, 2024
    Ultrasound Breast 400
    Higher social support tied to more breast cancer screening
    By Amerigo Allegretto
    More social support and living with a spouse or partner are tied to more breast cancer screening, according to an ACS study.
    October 17, 2024
    Patient Doctor Women
    Sectra inks 5-year deal with MaineGeneral Health
    By AuntMinnie.com staff writers
    Sectra has secured a five-year agreement with MaineGeneral Health to use Sectra One Cloud and its modules for radiology and breast imaging.
    October 15, 2024
    Sectra Rsna 2019 400
    Kaiser scoring with CEM boosts diagnostic accuracy for breast masses
    By Amerigo Allegretto
    Kaiser scoring for contrast-enhanced mammography (CEM) demonstrated comparable diagnostic accuracy to that of MRI in distinguishing breast masses.
    October 14, 2024
    Contrast Injector
    First breast cancer factors impact mammo's ability to find future ones
    By Amerigo Allegretto
    Some factors tied to first breast cancers can have a negative impact on screening mammography when finding future cancers.
    October 9, 2024
    Mammo Reading 400
    Mammogram reads improve when arranged from low to high breast density
    By Amerigo Allegretto
    Screening mammography exams arranged from low to high breast density can boost radiologists' interpretation performance.
    October 8, 2024
    Images Large Radiol 240237 fig1 67056a35a0e37
    AI scoring predicts future breast cancer risk
    By Amerigo Allegretto
    AI scoring could help predict future breast cancer risk and identify high-risk women.
    October 4, 2024
    Breast Mammo Computer
    Experts talk breast imaging's 2024 for Breast Cancer Awareness Month
    By Amerigo Allegretto
    As the U.S. celebrates this year's Breast Cancer Awareness Month, radiology experts and advocates reflect on the big year breast imaging has had.
    October 3, 2024
    Pink Ribbon Social
    ASTRO: Shorter radiation course safe for breast reconstruction
    By Amerigo Allegretto
    Research presented at the ASTRO annual meeting shows that a shorter course of postmastectomy radiation combined with breast reconstruction is safe.
    October 2, 2024
    Breast Cancer3 400
    Page 1 of 679
    Next Page